@article{b1c1ea5eff264601b716d2eda4610d3d,
title = "Myocardial perfusion imaging: Lessons learned and work to be done—update",
abstract = "As the second term of our commitment to Journal begins, we, the editors, would like to reflect on a few topics that have relevance today. These include prognostication and paradigm shifts; Serial testing: How to handle data? Is the change in perfusion predictive of outcome and which one? Ischemia-guided therapy: fractional flow reserve vs perfusion vs myocardial blood flow; positron emission tomography (PET) imaging using Rubidium-82 vs N-13 ammonia vs F-18 Flurpiridaz; How to differentiate microvascular disease from 3-vessel disease by PET? The imaging scene outside the United States, what are the differences and similarities? Radiation exposure; Special issues with the new cameras? Is attenuation correction needed? Are there normal databases and are these specific to each camera system? And finally, hybrid imaging with single-photon emission tomography or PET combined with computed tomography angiography or coronary calcium score. We hope these topics are of interest to our readers.",
keywords = "Myocardial perfusion imaging, coronary artery disease, nuclear imaging, positron emission tomography, prognosis, single-photon emission tomography",
author = "Iskandrian, {Ami E.} and Vasken Dilsizian and Garcia, {Ernest V.} and Beanlands, {Rob S.} and Manuel Cerqueira and Prem Soman and Berman, {Daniel S.} and Alberto Cuocolo and Einstein, {Andrew J.} and Morgan, {Charity J.} and Hage, {Fadi G.} and Schelbert, {Heinrich R.} and Bax, {Jeroen J.} and Wu, {Joseph C.} and Shaw, {Leslee J.} and Sadeghi, {Mehran M.} and Nagara Tamaki and Kaufmann, {Philipp A.} and Robert Gropler and Sharmila Dorbala and {Van Decker}, William",
note = "Funding Information: Ernest V Garcia: Royalties from sale of medical software, shares of Syntermed. Rob S. Beanlands: Consultant: GE, JubilantDraxImage, Lanthues; Research Grants from Jubi-lantDraxImage, Lantheus. Manuel Cerqueira: Consultant: Astellas Pharma USA, GE; Speakers Bureau: Astellas Pharma USA. Prem Soman: Grant funding to institution: Astellas Pharma; Advisory Board: Alnylam Pharma. Daniel S. Ber-man: Software Royalties from Cedars-Sinai Medical Center. Andrew J Einstein: Grant funding to institution: GE Healthcare, Philips Healthcare, Toshiba America Medical Systems. Advisory board: GE Healthcare. Fadi G. Hage: Grant support: Astellas Pharma, Novartis Pharma. Jeroen J Bax: The Dept of Leiden University Medical Center, The Netherlands, has received unrestricted research grants from Bio-tronik, Medtronic, Boston Scientific and Edwards Lifescience. Mehran M. Sadeghi: Consultant Bracco Research USA. Nagara Tamaki: Grant funding to institution: Nihon Medi-Physics Co Ltd. and Fuji-Film RI Pharma Co Ltd. Philipp A. Kaufmann: The Department of Nuclear Medicine, University Hospital Zurich holds a Research contract with GE Healthcare. Robert Gropler: Consultant Biomedical Systems. Shar-mila Dorbala: Research grant Astellas Pharma; Stockownership GE. All others authors have nothing to disclosure. Publisher Copyright: {\textcopyright} 2017, American Society of Nuclear Cardiology.",
year = "2018",
month = feb,
day = "1",
doi = "10.1007/s12350-017-1093-7",
language = "English",
volume = "25",
pages = "39--52",
journal = "Journal of Nuclear Cardiology",
issn = "1071-3581",
number = "1",
}